KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Non-Current Debt (2016 - 2023)

Exact Sciences (EXAS) has disclosed Non-Current Debt for 14 consecutive years, with $50.0 million as the latest value for Q1 2023.

  • On a quarterly basis, Non-Current Debt changed N/A to $50.0 million in Q1 2023 year-over-year; TTM through Mar 2023 was $50.0 million, a N/A change, with the full-year FY2022 number at $50.0 million, changed N/A from a year prior.
  • Non-Current Debt was $50.0 million for Q1 2023 at Exact Sciences, roughly flat from $50.0 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $50.0 million in Q2 2022 to a low of $21.4 million in Q3 2021.
  • A 5-year average of $31.3 million and a median of $24.0 million in 2019 define the central range for Non-Current Debt.
  • Peak YoY movement for Non-Current Debt: skyrocketed 2682.35% in 2019, then fell 7.03% in 2020.
  • Exact Sciences' Non-Current Debt stood at $24.0 million in 2019, then decreased by 7.03% to $22.3 million in 2020, then dropped by 4.05% to $21.4 million in 2021, then skyrocketed by 133.23% to $50.0 million in 2022, then changed by 0.0% to $50.0 million in 2023.
  • Per Business Quant, the three most recent readings for EXAS's Non-Current Debt are $50.0 million (Q1 2023), $50.0 million (Q4 2022), and $50.0 million (Q3 2022).